Clinical Trial Comparing Single-administration of DA-5222 and Co-administration of DA-5222-R1, DA-5222-R2 and DA-5222-R3 in Healthy Adult Subjects in Fed State

NCT07046715 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DA-5222
DRUG: DA-5222-R1
DRUG: DA-5222-R2
DRUG: DA-5222-R3

Sponsor

Dong-A ST Co., Ltd.